Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Asks Hyloris For More Data On Maxigesic IV
Value Added Medicines Specialist Receives Complete Response Letter From US Agency
Jul 05 2022
•
By
David Wallace
The FDA has asked for more information as it examines Maxigesic IV • Source: Shutterstock
More from Value Added Medicines
More from Products